Medical Microinstruments gets FDA IDE for Symani Alzheimer's trial
NewsBytes | April 6, 2026 2:39 PM CST
REMIND trial targets deep cervical nodes
This study is all about targeting deep cervical lymph nodes, aiming to restore the brain's waste-clearing pathways and remove harmful proteins linked to Alzheimer's.
The surgery is super delicate because these vessels are tiny.
Over 30 days, researchers will track patient safety, and over six months, brain scans, and any changes in memory or thinking skills.
MMI's CEO calls it a new era for using robotics against tough diseases like Alzheimer's.
READ NEXT
-
Do facial with these fresh fruits in summer, skin will be hydrated, glowing and fresh…
-
Mom In Trouble For Sending Son With Extra Lunch For A Hungry Classmate
-
Life Gets Much Better For 3 Zodiac Signs After The Week Of April 6 – 12, 2026
-
Singapore Changi slips among world’s best airports for baggage delivery
-
How To Get Skyroot In Crimson Desert
